Pediatric cancer recurrence remains a daunting challenge for many families, especially for those faced with pediatric gliomas, a type of brain tumor that can be both treatable and prone to relapse.Recent advancements in AI cancer prediction have opened new avenues for understanding the factors that contribute to cancer relapse risk.